Universal Biosensors Inc (UBI) - Total Assets

Latest as of June 2025: AU$14.94 Million AUD ≈ $10.57 Million USD

Based on the latest financial reports, Universal Biosensors Inc (UBI) holds total assets worth AU$14.94 Million AUD (≈ $10.57 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore debt repayment capacity of Universal Biosensors Inc to assess how comfortably operating cash covers total debt obligations.

Universal Biosensors Inc - Total Assets Trend (2002–2024)

This chart illustrates how Universal Biosensors Inc's total assets have evolved over time, based on quarterly financial data. See net assets of Universal Biosensors Inc for net asset value and shareholders' equity analysis.

Universal Biosensors Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Universal Biosensors Inc's total assets of AU$14.94 Million consist of 71.5% current assets and 28.5% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$8.54 Million 33.1%
Accounts Receivable AU$3.14 Million 12.2%
Inventory AU$5.59 Million 21.6%
Property, Plant & Equipment AU$6.95 Million 26.9%
Intangible Assets AU$0.00 0.0%
Goodwill AU$0.00 0.0%

Asset Composition Trend (2002–2024)

This chart illustrates how Universal Biosensors Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Universal Biosensors Inc.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Universal Biosensors Inc's current assets represent 71.5% of total assets in 2024, an increase from 0.0% in 2002.
  • Cash Position: Cash and equivalents constituted 33.1% of total assets in 2024, up from 32.2% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
  • Asset Diversification: The largest asset category is cash and equivalents at 33.1% of total assets.

Universal Biosensors Inc Competitors by Total Assets

Key competitors of Universal Biosensors Inc based on total assets are shown below.

Company Country Total Assets
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
Germany €2.83 Billion
GN Store Nord
CO:GN
Denmark Dkr29.23 Billion
4DMEDICAL Ltd
AU:4DX
Australia AU$139.55 Million
Getein Biotech Inc
SHG:603387
China CN¥3.70 Billion
Ningbo David Medical Device Co Ltd
SHE:300314
China CN¥1.45 Billion
Vieworks Co. Ltd
KQ:100120
Korea ₩351.89 Billion
Somnomed Ltd
AU:SOM
Australia AU$79.90 Million

Universal Biosensors Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.90 5.65 3.03
Quick Ratio 1.13 4.45 2.84
Cash Ratio 0.52 0.00 0.00
Working Capital AU$3.81 Million AU$21.00 Million AU$21.93 Million

Universal Biosensors Inc - Advanced Valuation Insights

This section examines the relationship between Universal Biosensors Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.59
Latest Market Cap to Assets Ratio 0.11
Asset Growth Rate (YoY) -13.8%
Total Assets AU$25.84 Million
Market Capitalization $2.95 Million USD

Valuation Analysis

Below Book Valuation: The market values Universal Biosensors Inc's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Universal Biosensors Inc's assets decreased by 13.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Universal Biosensors Inc (2002–2024)

The table below shows the annual total assets of Universal Biosensors Inc from 2002 to 2024.

Year Total Assets Change
2024-12-31 AU$25.84 Million
≈ $18.28 Million
-13.79%
2023-12-31 AU$29.97 Million
≈ $21.21 Million
-35.05%
2022-12-31 AU$46.15 Million
≈ $32.65 Million
+3.69%
2021-12-31 AU$44.50 Million
≈ $31.49 Million
-21.07%
2020-12-31 AU$56.38 Million
≈ $39.89 Million
-10.02%
2019-12-31 AU$62.66 Million
≈ $44.34 Million
-10.46%
2018-12-31 AU$69.98 Million
≈ $49.51 Million
+51.26%
2017-12-31 AU$46.26 Million
≈ $32.73 Million
-7.46%
2016-12-31 AU$49.99 Million
≈ $35.37 Million
+11.21%
2015-12-31 AU$44.95 Million
≈ $31.81 Million
-5.43%
2014-12-31 AU$47.53 Million
≈ $33.63 Million
-12.98%
2013-12-31 AU$54.62 Million
≈ $38.65 Million
+11.32%
2012-12-31 AU$49.07 Million
≈ $34.72 Million
+8.52%
2011-12-31 AU$45.22 Million
≈ $31.99 Million
-16.01%
2010-12-31 AU$53.84 Million
≈ $38.09 Million
-4.00%
2009-12-31 AU$56.08 Million
≈ $39.68 Million
+2.55%
2008-12-31 AU$54.69 Million
≈ $38.69 Million
-14.36%
2007-12-31 AU$63.86 Million
≈ $45.18 Million
+60.11%
2006-12-31 AU$39.88 Million
≈ $28.22 Million
+823.84%
2005-12-31 AU$4.32 Million
≈ $3.05 Million
+2.01%
2004-12-31 AU$4.23 Million
≈ $2.99 Million
+1.39%
2003-12-31 AU$4.17 Million
≈ $2.95 Million
+168.94%
2002-12-31 AU$1.55 Million
≈ $1.10 Million
--

About Universal Biosensors Inc

AU:UBI Australia Medical Devices
Market Cap
$2.95 Million
AU$4.17 Million AUD
Market Cap Rank
#29496 Global
#1672 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.02
All Time High
AU$1.00
About

Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more